Aadi Bioscience, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aadi Bioscience, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Aadi Bioscience, Inc. Return On Equity for the quarter ending September 30, 2024 was -71.9 %, a 57% decline year-over-year.
  • Aadi Bioscience, Inc. annual Return On Equity for 2023 was -52.5 %, a 21.7% decline from 2022.
  • Aadi Bioscience, Inc. annual Return On Equity for 2022 was -43.2 %, a 75.5% increase from 2021.
  • Aadi Bioscience, Inc. annual Return On Equity for 2021 was -176 %, a 897% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -71.9 -26.1 -57% Jul 1, 2024 Sep 30, 2024
Q2 2024 -66.7 -26 -63.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -61.8 -19.3 -45.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.5 -9.37 -21.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -45.8 +0.68 +1.46% Jul 1, 2023 Sep 30, 2023
Q2 2023 -40.7 +63.1 +60.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.5 +78.2 +64.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.2 +133 +75.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -46.5 +294 +86.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -104 -115 -1067% Apr 1, 2022 Jun 30, 2022
Q1 2022 -121 -154 -467% Jan 1, 2022 Mar 31, 2022
Q4 2021 -176 -198 -897% Oct 1, 2021 Dec 31, 2021
Q3 2021 -340 -447 -418% Jul 1, 2021 Sep 30, 2021
Q2 2021 10.7 +2.73K Apr 1, 2021 Jun 30, 2021
Q1 2021 32.9 +143 Jan 1, 2021 Mar 31, 2021
Q4 2020 22.1 +94.2 Oct 1, 2020 Dec 31, 2020
Q3 2020 107 +163 Jul 1, 2020 Sep 30, 2020
Q2 2020 -2.72K -2.7K -13424% Apr 1, 2020 Jun 30, 2020
Q1 2020 -110 -89.3 -436% Jan 1, 2020 Mar 31, 2020
Q4 2019 -72.1 -49.5 -219% Oct 1, 2019 Dec 31, 2019
Q3 2019 -55.6 -32.9 -145% Jul 1, 2019 Sep 30, 2019
Q2 2019 -20.1 +77.2 +79.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -20.5 +98.8 +82.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -22.6 +61.3 +73.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -22.7 -4.83K -100% Jul 1, 2018 Sep 30, 2018
Q2 2018 -97.3 -398 -132% Apr 1, 2018 Jun 30, 2018
Q1 2018 -119 -253 -189% Jan 1, 2018 Mar 31, 2018
Q4 2017 -83.8 -162 -207% Oct 1, 2017 Dec 31, 2017
Q3 2017 4.8K +4.72K +5885% Jul 1, 2017 Sep 30, 2017
Q2 2017 301 +249 +487% Apr 1, 2017 Jun 30, 2017
Q1 2017 133 +108 +430% Jan 1, 2017 Mar 31, 2017
Q4 2016 78.3 +78.1 +41624% Oct 1, 2016 Dec 31, 2016
Q3 2016 80.3 +61.3 Jul 1, 2016 Sep 30, 2016
Q2 2016 51.2 +31.4 Apr 1, 2016 Jun 30, 2016
Q1 2016 25.2 +4.47 Jan 1, 2016 Mar 31, 2016
Q4 2015 0.19 -21.6 -99.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 19* -2.64 Jul 1, 2015 Sep 30, 2015
Q2 2015 19.9* -2.76 Apr 1, 2015 Jun 30, 2015
Q1 2015 20.7* -3.12 Jan 1, 2015 Mar 31, 2015
Q4 2014 21.8 -3.8 -14.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 21.6* -5.63 Jul 1, 2014 Sep 30, 2014
Q2 2014 22.6* -6.51 Apr 1, 2014 Jun 30, 2014
Q1 2014 23.8* -7.12 Jan 1, 2014 Mar 31, 2014
Q4 2013 25.6 -7.11 -21.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 27.3* -7.41 Jul 1, 2013 Sep 30, 2013
Q2 2013 29.1* -9.23 Apr 1, 2013 Jun 30, 2013
Q1 2013 30.9* -12.2 Jan 1, 2013 Mar 31, 2013
Q4 2012 32.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 34.7* Jul 1, 2012 Sep 30, 2012
Q2 2012 38.4* Apr 1, 2012 Jun 30, 2012
Q1 2012 43.2* Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.